In children with retinoblastoma whose tumor had grown into the optic nerve, not receiving chemotherapy after removal of the eyeball was linked to higher risks for cancer recurrence in the eye socket, ...

Adjuvant Chemotherapy after Surgery in Stage II and III Colon Cancer: The Sooner the Better? In surgically resectable disease, adjuvant chemotherapy has been clearly demonstrated to increase the ...

Interactive Use of Cox Model–Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML Using multicenter observational data (2010-2022), we emulated ...

A new case report was published in Volume 17 of Oncotarget on May 4, 2026, titled “Laryngeal leiomyosarcoma: A rare case ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

An international study shows that cancer survivors who get moving after chemo can increase their chances of beating colon cancer, making exercise a game-changer for long-term survival. Study: ...

Please provide your email address to receive an email when new articles are posted on . A 14-gene molecular assay may help predict adjuvant chemotherapy benefit in early NSCLC. Patients assigned ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® ...

New approvals for fam-trastuzumab deruxtecan-nxki establish a potential new standard of care in the neoadjuvant and adjuvant settings for patients with HER2-positive early breast cancer.